No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SCLX240816C1500
- 0.50
- -0.55-52.38%
15min DelayTrading Jul 22 09:55 ET
0.50High0.50Low
0.50Open1.05Pre Close8 Volume3 Open Interest1.50Strike Price400.00Turnover212.47%IV13.31%PremiumAug 16, 2024Expiry Date0.27Intrinsic Value100Multiplier25DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type0.7129Delta0.3468Gamma3.53Leverage Ratio-0.0067Theta0.0005Rho2.52Eff Leverage0.0016Vega
Intraday
- 5D
- Daily
News
Express News | Scilex Selling Shareholder Files For Sale Of Up To 3.5M Shares
Express News | Scilex Holding Co Files for Offering of up to 3.5 Mln Common Shares by the Selling Securityholders - SEC Filing
Non-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ Debut
Semnur Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company (NASDAQ:SCLX), and Denali Capital Acquisition Corp. (NASDAQ:DECA), a special purpose acquisition company, signed a lett
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday
Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently. CureVac (CVAC) and GSK (GSK) said they re
Express News | Scilex Holding Pares Gain in Premarket, Last up 7.7%
Trending Stocks Today: VivoPower Shoots up 120.66% Pre-Market
July 3rd - US stocks trending pre-market: Gainers: $VivoPower(VVPR.US)$ shoots up 120.66% to $3.31 with a turnover of $51.85 million. $CNS Pharmaceuticals(CNSP.US)$ surges 93.65% to $2.44 with a turno
Comments
$Scilex Holding(SCLX.US$
Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region
Scilex Holding Company (Nasdaq: SCLX) has entered a Memorandum of Understanding (MOU) with ACEA Therapeutics for collaboration on ZTlido®, a lidocaine topical system for neuropathic pain relief. The a...
Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region
Scilex Holding Company (Nasdaq: SCLX) has entered a Memorandum of Understanding (MOU) with ACEA Therapeutics for collaboration on ZTlido®, a lidocaine topical system for neuropathic pain relief. The a...
2
9
$Scilex Holding(SCLX.US$ $Denali Capital Acquisition Corp(DECA.US$ Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: Deca) Enter Into a Letter of Intent for a Proposed Business Combination! Transaction value upto 2 billion!
3
$Scilex Holding(SCLX.US$
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
▪️The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and research. PAIN is the official journal of the Internation...
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
▪️The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and research. PAIN is the official journal of the Internation...
2
Read more